Two New Pre-Clinical Contracts

RNS Number : 4987M

Physiomics PLC

31 July 2017

 

Physiomics plc

("Physiomics") or ("the Company")

Two new pre-clinical contracts

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has today signed two new contracts with a global pharma company for Virtual Tumour pre-clinical predictions relating to a new oncology target.  This marks the sixth year of collaboration with this company since a first pre-clinical project was announced in March 2012.

The two contracts will be executed in parallel between now and the end of the calendar year.

Jim Millen, CEO said: "We are delighted by these new contracts which we believe are a sign of the client's long-term commitment to Physiomics and its Virtual Tumour technology.  We look forward to continuing to work closely with them going forwards".

This announcement refers to a contract in the ordinary course of business for Physiomics.

Enquiries:

Physiomics plc                                                  

Dr Jim Millen, CEO

[phone]

WH Ireland Limited (nomad)

Katy Mitchell

[phone]

Hybridan LLP (broker)

Claire Louise Noyce

[phone]

 

END

 

 

CNTLLFVRDEITFID